[HTML][HTML] Treatment of type 2 diabetes mellitus worldwide: baseline patient characteristics in the global DISCOVER study
MB Gomes, W Rathmann, B Charbonnel… - Diabetes research and …, 2019 - Elsevier
… or combination therapies, and patients who were prescribed an … of the study is to provide a
global picture of type 2 diabetes … DISCOVER therefore provides unique insights into treatment …
global picture of type 2 diabetes … DISCOVER therefore provides unique insights into treatment …
Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies
HC Kenny, ED Abel - Circulation research, 2019 - Am Heart Assoc
… Type 2 diabetes mellitus (T2DM) is a global epidemic and is expected to affect over 592
million people worldwide by 2035, a dramatic increase from 382 million people with diabetes …
million people worldwide by 2035, a dramatic increase from 382 million people with diabetes …
… cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular …
… type 2 diabetes, we reported a modest reduction in atherosclerotic cardiovascular events and
an increased risk of heart failure, … intervention type. In view of the completion of many large …
an increased risk of heart failure, … intervention type. In view of the completion of many large …
Genetics insights in the relationship between type 2 diabetes and coronary heart disease
MO Goodarzi, JI Rotter - Circulation research, 2020 - Am Heart Assoc
… T2D is a worldwide epidemic. The incidence of … This review will explore the relationship
between T2D and CHD, focusing on insights derived from genetic studies that have exploited the …
between T2D and CHD, focusing on insights derived from genetic studies that have exploited the …
Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes
… This study evaluated the application of a biomarker-based risk score to identify individuals
with dysglycemia who are at high risk for incident heart failure (HF) and to inform allocation of …
with dysglycemia who are at high risk for incident heart failure (HF) and to inform allocation of …
[HTML][HTML] Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes
JJ Park - Diabetes & metabolism journal, 2021 - synapse.koreamed.org
… 592 million people worldwide will have diabetes by 2035. … diabetes duration, ischemic
heart disease, greater body weight, and higher creatinine level, among others; therefore,patients …
heart disease, greater body weight, and higher creatinine level, among others; therefore,patients …
Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review
K McHugh, AD DeVore, J Wu, RA Matsouaka… - Journal of the American …, 2019 - jacc.org
… outcomes of patients with comorbid HFpEF and DM globally. For … abnormalities, and congenital
heart disease may be common … Further research using global HF registries is needed to …
heart disease may be common … Further research using global HF registries is needed to …
Phenotypic refinement of heart failure in a national biobank facilitates genetic discovery
KG Aragam, M Chaffin, RT Levinson, G McDermott… - Circulation, 2019 - Am Heart Assoc
… affects >30 million individuals worldwide with a projected ≈40… The rising global burden of
HF and its apparent heritability, … loci and offers biological insights into cardiovascular risk.Nat …
HF and its apparent heritability, … loci and offers biological insights into cardiovascular risk.Nat …
Health-related quality of life and mortality in heart failure: the global congestive heart failure study of 23 000 patients from 40 countries
I Johansson, P Joseph, K Balasubramanian… - Circulation, 2021 - Am Heart Assoc
… The G-CHF study (Global Congestive Heart Failure) is the largest study to systematically …
the Kansas City Cardiomyopathy Questionnaire–12) and its association with heart failure (HF) …
the Kansas City Cardiomyopathy Questionnaire–12) and its association with heart failure (HF) …
… the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA …
JJV McMurray, DL DeMets, SE Inzucchi… - … of heart failure, 2019 - Wiley Online Library
… Firstly, in many parts of the world (but particularly in the USA) considerable effort has been
made to … Two other key secondary endpoints also reflect new insights into the experience of …
made to … Two other key secondary endpoints also reflect new insights into the experience of …